Skip to main content
. 2022 Feb 2;8(3):FSO783. doi: 10.2144/fsoa-2021-0126

Figure 1. . Immunoglobulin M and G in SARS-CoV-2 patients.

Figure 1. 

(A) Antibody response to five SARS-CoV-2 epitopes in ICU patients versus general medical ward patients was assessed in GRUs for IgM and IgG. (B) Antibody response at a median of 8 days after symptom onset. Patients requiring ICU admission had lower levels of IgM against the nucleocapsid protein (CoV2NC.IgM) and higher levels of IgG against three out of four S protein domains (CoV2S1.IgG, CoV2S1S2.IgG, CoV2S2.IgG) compared with those who were managed on general medical floors (ward group).

*p < 0.05; **p < 0.01.

GRUs: Genalyte response units; ICU: Intensive care unit; Ig: Immunoglobulin.